Dicerna Pharmaceuticals, Inc. Pre-Tax Profit Margin 2013-2021 | DRNA
Dicerna Pharmaceuticals, Inc. pre-tax profit margin from 2013 to 2021. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Pre-Tax Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Pre-Tax Income | Pre-Tax Margin |
| 2021-09-30 | $0.19B | $-0.12B | -63.73% |
| 2021-06-30 | $0.18B | $-0.13B | -72.07% |
| 2021-03-31 | $0.18B | $-0.12B | -67.98% |
| 2020-12-31 | $0.16B | $-0.11B | -68.90% |
| 2020-09-30 | $0.13B | $-0.12B | -89.23% |
| 2020-06-30 | $0.09B | $-0.13B | -140.45% |
| 2020-03-31 | $0.06B | $-0.12B | -212.73% |
| 2019-12-31 | $0.02B | $-0.12B | -504.17% |
| 2019-09-30 | $0.02B | $-0.10B | -526.32% |
| 2019-06-30 | $0.01B | $-0.09B | -676.92% |
| 2019-03-31 | $0.01B | $-0.10B | -1111.11% |
| 2018-12-31 | $0.01B | $-0.09B | -1125.00% |
